Table 2.
Subgroup analysis
| Categories | N | Pooled RR | 95% CI | P value | Heterogeneity | |
|---|---|---|---|---|---|---|
| I2 | P′ | |||||
| Study design | ||||||
| Cohort | 13 | 0.78 | 0.66–0.91 | <0.001 | 90.4% | <0.001 |
| Case-control | 4 | 0.78 | 0.65–0.94 | <0.001 | 0% | 0.526 |
| Cancer location | ||||||
| Colon | 6 | 0.68 | 0.55–0.83 | <0.001 | 86.2% | <0.001 |
| Rectum | 5 | 0.89 | 0.83–0.95 | <0.001 | 0 | 0.887 |
| Geographical region | ||||||
| America | 3 | 0.58 | 0.46–0.74 | <0.001 | 0 | 0.957 |
| Europe | 6 | 0.82 | 0.74–0.90 | <0.001 | 51% | 0.070 |
| Asia | 4 | 0.83 | 0.51–1.34 | 0.442 | 97% | <0.001 |
Abbreviations: N number of studies, RR relative risk, CI confidence intervals, P′ p value of I2 statistics for heterogeneity